Results 251 to 260 of about 10,329,681 (281)

Secondary negative symptoms — A review of mechanisms, assessment and treatment [PDF]

open access: yesSchizophrenia Research, 2017
Negative symptoms in schizophrenia may be classified as primary or secondary. Primary negative symptoms are thought to be intrinsic to schizophrenia, while secondary negative symptoms are caused by positive symptoms, depression, medication side-effects ...
André Aleman   +2 more
exaly   +2 more sources

Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study

open access: yesSchizophrenia Research, 2022
Negative symptoms represent one of the core features of schizophrenia spectrum disorders (SSD), strongly correlated with low remission rates, poor real-world functioning, and worse quality of life.
Paolo Valsecchi   +2 more
exaly   +2 more sources

Persistent negative symptoms in first-episode schizophrenia: A prospective three-year follow-up study

open access: yesSchizophrenia Research, 2011
Background: Negative symptoms are a core feature of schizophrenia. The evolution and trajectory of primary negative symptoms were under-studied. We aimed at evaluating the prevalence and stability of primary negative symptoms, and factors associated with
Christy L M Hui   +2 more
exaly   +2 more sources

Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis [PDF]

open access: yesEuropean Archives of Psychiatry and Clinical Neuroscience, 2018
BACKGROUND Negative symptoms are the core of schizophrenia, but whether antipsychotics are efficacious for their treatment is unclear. Moreover, there is debate whether patients in relevant trials should have predominant negative symptoms or whether ...
Adriani Nikolakopoulou   +2 more
exaly   +4 more sources

PINV - Topography and Primary Negative Symptoms in Chronic Schizophrenia

Pharmacopsychiatry, 1994
PINV was recorded during a warned reaction time paradigm in 16 chronic schizophrenics in remission. Clinical symptoms were assessed by BPRS, SANS, and the anhedonia scale of the Chapman Questionnaire. Ten healthy controls were studied in the same manner.
G, Eikmeier, E, Lodemann
openaire   +2 more sources

Primary enduring negative symptoms in schizophrenia and major depression

Journal of Psychiatric Research, 1995
Primary enduring negative symptoms (PENS) were studied in 26 patients with DSM-III-R schizophrenia and in 94 patients with unipolar major depressive episodes 5 years after the index episode. PENS were assessed with the Schedule for Deficit Syndrome (SDS). Negative symptoms were also assessed with the Scale for Assessment of Negative Symptoms (SANS) and
H, Gerbaldo   +5 more
openaire   +2 more sources

Correspondence between negative symptoms and potential sources of secondary negative symptoms over time [PDF]

open access: yesEuropean Archives of Psychiatry and Clinical Neuroscience, 2017
There has been a debate in the literature about the distinction between primary and secondary negative symptoms of schizophrenia. Our aim was to study the associations between negative symptoms and potential sources of secondary negative symptoms over ...
Stefan Priebe, Mark Savill, Aida Farreny
exaly   +2 more sources

d-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia

Schizophrenia Research, 2002
D-Cycloserine, a partial agonist at the glycine recognition site of the NMDA receptor has previously been shown to improve negative symptoms when added to conventional antipsychotics and to worsen negative symptoms when added to clozapine. The purpose of this study was to examine the effects of D-cycloserine when added to risperidone on negative ...
A Eden, Evins   +4 more
openaire   +2 more sources

Negative Symptoms in a Depressed Teen? Primary Hyperparathyroidism and its Psychiatric Manifestations

Journal of Child and Adolescent Psychopharmacology, 2015
[Author Affiliation]Timothy Rice. Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, New York.Svetlana Azova. Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, New York.Barbara J. Coffey. Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, New York.Address correspondence to ...
Timothy, Rice   +2 more
openaire   +2 more sources

Improvement of Schizophrenic Patients With Primary Negative Symptoms Treated With Amisulpride

American Journal of Psychiatry, 1999
OBJECTIVE: The goal of this placebo-controlled study was to evaluate the efficacy and safety of low doses of amisulpride, an atypical antipsychotic of the benzamide class with high affinity for D2 and D3 dopamine receptors, in the treatment of schizophrenic patients with predominantly primary negative symptoms.
Jean-Marie Danion   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy